These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8039848)
1. Phosphoramidon-sensitive conversion of big endothelin-1 and degradation of endothelin-1 in rat kidney. Fujita K; Matsumura Y; Kita S; Hisaki K; Takaoka M; Morimoto S Hypertension; 1994 Aug; 24(2):227-33. PubMed ID: 8039848 [TBL] [Abstract][Full Text] [Related]
2. Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme. Hisaki K; Matsumura Y; Maekawa H; Fujita K; Takaoka M; Morimoto S Am J Physiol; 1994 Feb; 266(2 Pt 2):H422-8. PubMed ID: 8141343 [TBL] [Abstract][Full Text] [Related]
3. Phosphoramidon inhibits the conversion of big ET-1 into ET-1 in the pithed rat and in isolated perfused rat kidneys. Verbeuren TJ; Mennecier P; Merceron D; Simonet S; de Nanteuil G; Vincent M; Laubie M J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S81-4. PubMed ID: 7510006 [TBL] [Abstract][Full Text] [Related]
4. Differences in potency of big endothelin-1-induced pressor action in rat isolated perfused mesenteric artery, hindquarter and lung. Hisaki K; Matsumura Y; Fujita K; Maekawa H; Takaoka M; Morimoto S Life Sci; 1994; 54(4):275-80. PubMed ID: 8289588 [TBL] [Abstract][Full Text] [Related]
5. Evidence for phosphoramidon-sensitive conversion of big endothelin-1 to endothelin-1 in isolated rat mesenteric artery. Hisaki K; Matsumura Y; Ikegawa R; Nishiguchi S; Hayashi K; Takaoka M; Morimoto S Biochem Biophys Res Commun; 1991 Jun; 177(3):1127-32. PubMed ID: 2059203 [TBL] [Abstract][Full Text] [Related]
6. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats. McMahon EG; Palomo MA; Moore WM J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S29-33. PubMed ID: 1725358 [TBL] [Abstract][Full Text] [Related]
7. In vivo characterization of a phosphoramidon-sensitive endothelin-converting enzyme in the rat. Pollock DM; Divish BJ; Milicic I; Novosad EI; Burres NS; Opgenorth TJ Eur J Pharmacol; 1993 Feb; 231(3):459-64. PubMed ID: 8449237 [TBL] [Abstract][Full Text] [Related]
8. Endothelium-independent pressor effect of big endothelin-1 and its inhibition by phosphoramidon in rat mesenteric artery. Hisaki K; Matsumura Y; Nishiguchi S; Fujita K; Takaoka M; Morimoto S Eur J Pharmacol; 1993 Sep; 241(1):75-81. PubMed ID: 8223929 [TBL] [Abstract][Full Text] [Related]
9. Effects of phosphoramidon on endothelin-1 and big endothelin-1 production in human aortic endothelial cells. Matsumura Y; Tsukahara Y; Kojima T; Murata S; Murakami A; Takada K; Takaoka M; Morimoto S Biol Pharm Bull; 1995 Mar; 18(3):401-6. PubMed ID: 7550091 [TBL] [Abstract][Full Text] [Related]
10. Phosphoramidon-sensitive effects of big endothelins in the perfused rabbit kidney. Télémaque S; Lemaire D; Claing A; D'Orléans-Juste P Hypertension; 1992 Oct; 20(4):518-23. PubMed ID: 1398887 [TBL] [Abstract][Full Text] [Related]
11. Intrarenal conversion of big endothelin-1 to endothelin-1 in the rat. Fujita K; Matsumura Y; Kita S; Hisaki K; Takaoka M; Morimoto S Life Sci; 1994; 55(16):1285-91. PubMed ID: 7934630 [TBL] [Abstract][Full Text] [Related]
13. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats. McMahon EG; Palomo MA; Brown MA; Bertenshaw SR; Carter JS Am J Hypertens; 1993 Aug; 6(8):667-73. PubMed ID: 8217029 [TBL] [Abstract][Full Text] [Related]
14. Endothelin-converting enzyme and its in vitro and in vivo inhibition. Yano M; Okada K; Takada J; Hioki Y; Matsuyama K; Fukuroda T; Noguchi K; Nishikibe M; Ikemoto F J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S26-8. PubMed ID: 1725349 [TBL] [Abstract][Full Text] [Related]
15. Phosphoramidon-sensitive endothelin converting enzyme in cultured vascular smooth muscle cells converts big endothelin-3 to endothelin-3. Tsukahara Y; Matsumura Y; Kuninobu K; Kojima T; Takaoka M; Morimoto S Life Sci; 1993; 53(6):465-71. PubMed ID: 8341132 [TBL] [Abstract][Full Text] [Related]
16. Human big endothelin releases prostacyclin in vivo and in vitro through a phosphoramidon-sensitive conversion to endothelin-1. D'Orléans-Juste P; Lidbury PS; Telemaque S; Warner TD; Vane JR J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S251-5. PubMed ID: 1725347 [TBL] [Abstract][Full Text] [Related]
17. Conversion of big endothelin-1 to endothelin-1 by phosphoramidon-sensitive metalloproteinase derived from aortic endothelial cells. Matsumura Y; Ikegawa R; Hisaki K; Tsukahara Y; Takaoka M; Morimoto S J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S65-7. PubMed ID: 1725435 [TBL] [Abstract][Full Text] [Related]
18. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. McMahon EG; Palomo MA; Moore WM; McDonald JF; Stern MK Proc Natl Acad Sci U S A; 1991 Feb; 88(3):703-7. PubMed ID: 1992461 [TBL] [Abstract][Full Text] [Related]
19. Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Ikegawa R; Matsumura Y; Tsukahara Y; Takaoka M; Morimoto S Biochem Biophys Res Commun; 1990 Sep; 171(2):669-75. PubMed ID: 2206130 [TBL] [Abstract][Full Text] [Related]
20. Effect of phosphoramidon on big endothelin-2 conversion into endothelin-2 in human renal adenocarcinoma (ACHN) cells. Analysis of endothelin-2 biosynthetic pathway. Yorimitsu K; Shinmi O; Nishiyama M; Moroi K; Sugita Y; Saito T; Inagaki Y; Masaki T; Kimura S FEBS Lett; 1992 Dec; 314(3):395-8. PubMed ID: 1468574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]